Veerhealth Care Ltd Approves Preferential Allotment of One Crore Convertible Warrants
Veerhealth Care Ltd has announced the preferential allotment of 1,00,00,000 Fully Convertible Warrants in a recent corporate action. The warrants grant holders the right to subscribe to one Equity Share per Warrant for cash at an issue price of Rs.20.25 per warrant.The company finalized the allocation of these warrants across various categories of investors, including promoters and non-promoters. The total allotment ensures specific investments from key entities.
A detailed breakdown of the preferential allotment and the individuals who received the warrants is provided below:
| Sr. No | Name of Allottee | Category | Number of Warrants to be Allotted |
|---|---|---|---|
| 1 | Ruchi Yogesh Shah | Promoter | 6,85,000 |
| 2 | Shruti AkashShah | Promoter | 6,92,000 |
| 3 | Yogesh Mahasuklal Shah | Promoter | 12,50,000 |
| 4 | Yogesh Shah Huf | Promoter | 9,00,000 |
| 5 | Mahasuklal Shah Huf | Promoter | 4,50,000 |
| 6 | Krupa Harsh Jain | Promoter | 5,60,000 |
| 7 | Akash Lalabhai Patel | Non-Promoter | 12,60,000 |
| 8 | Kusumben Hiralal Shah | Non-Promoter | 14,01,000 |
| 9 | Ria. Shah | Non-Promoter | 14,01,000 |
| 10 | Panna Pankabhai Shah | Non-Promoter | 14,01,000 |
| Total | — | — | 1,00,00,000 |
The allotment decision was made by the Preferential Issue Committee of the Board of Directors. The committee meeting concerning this issue commenced at 03:30 P.M. and concluded at 4:20 P.M. on July 2, 2026.
Stock Price Movement
At the close of trade today, shares of Veerhealth Care Ltd settled at ₹32.47, marking a slight decline of 0.03%. The stock traded within an intraday range, reaching a high of ₹32.59 and touching a low of ₹32.25.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.